Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | IMSA101 |
Trade Name | |
Synonyms | IMSA-101|IMSA 101 |
Drug Descriptions |
IMSA101 is a cyclic GMP-AMP analog that functions as a STING1 agonist, which potentially activates immune cells resulting in enhanced antigen presentation and anti-tumor immune response (NCI Drug Dictionary). |
DrugClasses | STING1 Agonist 19 |
CAS Registry Number | NA |
NCIT ID | C165655 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
IMSA101 | IMSA101 | 0 | 1 |
IMSA101 + Nivolumab | IMSA101 Nivolumab | 0 | 3 |
IMSA101 + Pembrolizumab | IMSA101 Pembrolizumab | 0 | 2 |
IMSA101 + unspecified PD-1 antibody | IMSA101 unspecified PD-1 antibody | 0 | 1 |
IMSA101 + unspecified PD-L1 antibody | IMSA101 unspecified PD-L1 antibody | 0 | 1 |